Acute kidney injury in critically ill children with COVID-19 and MIS-C
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association..
BACKGROUND: This study's objective was to investigate the incidence of acute kidney injury (AKI) in children with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C) and to report our clinical experience.
METHODS: Acute COVID-19 and MIS-C-diagnosed patients observed in two pediatric intensive care units (PICUs) between 2019 and 2021 were examined for AKI and retrospectively compared to children with AKI.
RESULTS: The study comprised 163 children, of whom 98 (60.1%) were diagnosed with acute COVID-19 and 65 (39.9%) with MIS-C. AKI was observed in 40 (40.8%) of the acute COVID-19 patients and 18 (27.7%) of the MIS-C patients. Low calcium level and hypotension were linked with AKI at initial presentation (OR: 0.56, 95% CI: 0.369-0.560, p = 0.006 and OR: 3.64, 95% CI: 1.885-7.152, p = 0.001, respectively). A history of nephrotoxic medication usage played an essential role in the development of AKI in patients who acquired AKI after hospitalization (p = 0.001, odds ratio: 9.32, confidence interval: 3.106-27.973). In clinical practice, individuals with respiratory distress and cough had a high chance of having AKI (OR: 4.47, 95% confidence interval: 2.25-8,892 and OR: 3.48, 95% confidence interval: 1.76-6.88). AKI patients had a greater demand for respiratory assistance and a longer period of stay in the PICU.
CONCLUSIONS: AKI in the COVID-19 and MIS-C patient groups is related with increased mortality and extended hospitalization, according to the findings. These statistics imply that identifying and preventing risk factors is necessary. A higher resolution version of the Graphical abstract is available as Supplementary information.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Pediatric nephrology (Berlin, Germany) - 38(2023), 10 vom: 06. Okt., Seite 3475-3482 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Özen, Hasan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute kidney injury |
---|
Anmerkungen: |
Date Completed 31.08.2023 Date Revised 13.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00467-023-05987-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356744361 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356744361 | ||
003 | DE-627 | ||
005 | 20231226071121.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00467-023-05987-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1189.xml |
035 | |a (DE-627)NLM356744361 | ||
035 | |a (NLM)37171582 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Özen, Hasan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acute kidney injury in critically ill children with COVID-19 and MIS-C |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.08.2023 | ||
500 | |a Date Revised 13.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association. | ||
520 | |a BACKGROUND: This study's objective was to investigate the incidence of acute kidney injury (AKI) in children with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C) and to report our clinical experience | ||
520 | |a METHODS: Acute COVID-19 and MIS-C-diagnosed patients observed in two pediatric intensive care units (PICUs) between 2019 and 2021 were examined for AKI and retrospectively compared to children with AKI | ||
520 | |a RESULTS: The study comprised 163 children, of whom 98 (60.1%) were diagnosed with acute COVID-19 and 65 (39.9%) with MIS-C. AKI was observed in 40 (40.8%) of the acute COVID-19 patients and 18 (27.7%) of the MIS-C patients. Low calcium level and hypotension were linked with AKI at initial presentation (OR: 0.56, 95% CI: 0.369-0.560, p = 0.006 and OR: 3.64, 95% CI: 1.885-7.152, p = 0.001, respectively). A history of nephrotoxic medication usage played an essential role in the development of AKI in patients who acquired AKI after hospitalization (p = 0.001, odds ratio: 9.32, confidence interval: 3.106-27.973). In clinical practice, individuals with respiratory distress and cough had a high chance of having AKI (OR: 4.47, 95% confidence interval: 2.25-8,892 and OR: 3.48, 95% confidence interval: 1.76-6.88). AKI patients had a greater demand for respiratory assistance and a longer period of stay in the PICU | ||
520 | |a CONCLUSIONS: AKI in the COVID-19 and MIS-C patient groups is related with increased mortality and extended hospitalization, according to the findings. These statistics imply that identifying and preventing risk factors is necessary. A higher resolution version of the Graphical abstract is available as Supplementary information | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Acute kidney injury | |
650 | 4 | |a Multisystem inflammatory syndrome | |
650 | 4 | |a Pediatric intensive care | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Aslan, Ayşen Durak |e verfasserin |4 aut | |
700 | 1 | |a Balaban, Burak |e verfasserin |4 aut | |
700 | 1 | |a Perk, Oktay |e verfasserin |4 aut | |
700 | 1 | |a Uçmak, Hacer |e verfasserin |4 aut | |
700 | 1 | |a Özcan, Serhan |e verfasserin |4 aut | |
700 | 1 | |a Gurbanov, Anar |e verfasserin |4 aut | |
700 | 1 | |a Uyar, Emel |e verfasserin |4 aut | |
700 | 1 | |a Kahveci, Fevzi |e verfasserin |4 aut | |
700 | 1 | |a Gün, Emrah |e verfasserin |4 aut | |
700 | 1 | |a Tehci, Ali Kansu |e verfasserin |4 aut | |
700 | 1 | |a Emeksiz, Serhat |e verfasserin |4 aut | |
700 | 1 | |a Kendirli, Tanıl |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pediatric nephrology (Berlin, Germany) |d 1995 |g 38(2023), 10 vom: 06. Okt., Seite 3475-3482 |w (DE-627)NLM012612111 |x 1432-198X |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2023 |g number:10 |g day:06 |g month:10 |g pages:3475-3482 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00467-023-05987-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2023 |e 10 |b 06 |c 10 |h 3475-3482 |